NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIDCR E-229-2004-0-EP-05 Mammalian T1R3 Sweet Taste Receptors EP National Stage 04794142.2 Abandoned
NIDCR E-229-2004-0-HK-08 Mammalian T1R3 Sweet Taste Receptors HK EP 07100944.0 Abandoned
NIDCR E-229-2004-0-CA-06 Mammalian T1R3 Sweet Taste Receptors CA National Stage 2540837 Abandoned
NIDCR E-229-2004-0-AU-04 Mammalian T1R3 Sweet Taste Receptors AU National Stage 2004278425 Abandoned
NIDCR E-079-2007-0-US-01 Method Of Improving Drugs With Anti-retroviral And Anti-cancer Activity US 60/616,181 Abandoned
NCI E-060-2002-2-US-02 DNA-Binding Polyamide Drug Conjugates US National Stage 10/506,085 7605125 Abandoned PDF
NCI E-075-2003-0-PCT-02 Use of Cripto-1 as a Biomarker for Neurodegenerative Disease and Method of Inhibiting Progression Thereof PCT PCT PCT/US2004/32649 Expired
NCI E-291-2003-0-PCT-02 Building Blocks for DNA Binding Agents PCT PCT PCT/US2004/032617 Abandoned
NCI E-075-2003-0-EP-06 Use of Cripto-1 as a Biomarker for Neurodegenerative Disease and Method of Inhibiting Progression Thereof EP National Stage 04794121.6 Abandoned
NIDDK E-045-2005-0-US-01 METHODS OF USING GLYCOSAMINOGLYCANS FOR THE TREATMENT OF KIDNEY DISEASE US 60/615,472 Abandoned
NCI E-075-2003-0-AU-04 Use of Cripto-1 as a Biomarker for Neurodegenerative Disease and Method of Inhibiting Progression Thereof AU National Stage 2004278782 Abandoned
NCI E-075-2003-0-CA-05 Use of Cripto-1 as a Biomarker for Neurodegenerative Disease and Method of Inhibiting Progression Thereof CA National Stage 2539535 Abandoned
NCI E-272-2002-0-US-02 Serine Protease Inhibitors US ORD 10/957,266 7439226 Abandoned PDF
NIDDK E-324-2004-0-US-01 In Vitro Model For Hepatitis C Virion Production US 60/615,301 Abandoned
NCI E-327-2004-0-US-01 Macrocyclic SH2 Domain Binding Inhibitors US 60/614,800 Abandoned
NCI E-287-2004-0-US-01 IRTA2 ANTIBODIES AND METHODS OF USE US 60/615,406 Abandoned
NIAID E-221-2004-0-US-01 Chondroitin Sulphate A Binding Domains US 60/615,300 Abandoned
NCI E-316-2003-0-PCT-02 Immunoglobulins With Potent And Broad Antiviral Activity PCT PCT PCT/US2004/31878 Expired
CC E-083-2003-0-PCT-02 Intracellular Trapping Of Radionuclide Mediated By Enzymatic Reduction For Molecular Diagnositc Imaging And Radiotherapy PCT PCT PCT/US2004/031843 Expired
NCI E-316-2003-0-AU-06 Immunoglobulins With Potent And Broad Antiviral Activity AU National Stage 2004321500 Abandoned
NCI E-316-2003-0-CA-04 Immunoglobulins With Potent And Broad Antiviral Activity CA National Stage 2553788 Abandoned
NIMH E-276-2003-0-PCT-02 HIV-Dependent Expression Constructs and Uses Therefore PCT PCT PCT/US2004/031967 Expired
NIMH E-276-2003-0-EP-04 HIV-Dependent Expression Constructs and Uses Therefore EP National Stage 04789246.8 Abandoned
NIMH E-276-2003-0-CA-06 HIV-Dependent Expression Constructs and Uses Therefore CA National Stage 2540253 Abandoned
NIMH E-276-2003-0-AU-05 HIV-Dependent Expression Constructs and Uses Therefor AU National Stage 2004278761 Abandoned
NCI E-240-2001-0-US-04 Macromolecular Imaging Agents For Liver Imaging US National Stage 10/481,706 Abandoned
NCI E-137-2002-0-CA-05 METHOD FOR TREATING CANCER IN HUMANS CA National Stage 2481304 Abandoned
NCI E-349-2004-0-US-01 LRATLERIN, RELATED COMPOUNDS AND METHODS OF USE US 60/613,256 Abandoned
NCI E-188-2004-0-US-01 Nitric Oxide Releasing Diazeniumdiolated Derivatives Of Acrylonitrile-containing Polymers US 60/613,257 Abandoned
NCI E-257-2004-0-US-01 Modulating MxA Expression US 60/613,371 Abandoned
NIAID E-319-2004-0-US-01 Optimized Vaccines To Provide Protection Against Ebola And Other Viruses US 60/613,883 Abandoned
NHLBI E-240-1998-0-US-05 METHOD FOR DETERMINING IN VIVO CONCENTRATION OF A METABOLITE US DIV 10/948,942 7330748 Abandoned PDF
NHLBI E-208-2003-0-PCT-02 Identification Of An Endogenous TACE Inhibitory Peptide (eTIP) PCT PCT PCT/US2004/031608 Expired
NIA E-029-2004-0-US-02 Taste Signaling In Gastrointestinal Cells US National Stage 10/949,751 Abandoned
NCI E-137-2002-0-JP-07 METHOD FOR TREATING CANCER IN HUMANS JP National Stage 579755/2003 Abandoned
NIDCD E-174-2004-1-US-01 Moraxella (or Branhamella) Catarrhalis Is Viable Without Endotoxin, A Potential Vaccine Candidate US 60/613,139 Abandoned
NIA E-183-2003-0-CN-07 Method For Treating Cognitve Disorders CN National Stage 03806681.5 Abandoned
NIA E-183-2003-0-BE-19 Method For Treating Cognitve Disorders BE EP 03723773.2 Abandoned
NIA E-183-2003-0-ES-21 Method For Treating Cognitve Disorders ES EP 03723773.2 Abandoned
NIA E-183-2003-0-IT-20 Method For Treating Cognitve Disorders IT EP 03723773.2 Abandoned
NIA E-183-2003-0-NO-15 Method For Treating Cognitve Disorders NO National Stage 200404530 Abandoned
NIA E-183-2003-0-HR-09 Method For Treating Cognitve Disorders HR National Stage P20040992A Abandoned
NIA E-183-2003-0-JP-12 Method For Treating Cognitve Disorders JP National Stage 2003-579808 Abandoned
NIA E-183-2003-0-MX-14 Method For Treating Cognitve Disorders MX National Stage PA/a/2004/009136 Abandoned
NIAID E-241-2004-0-US-01 Method of Detecting Cancer Based On Immune Reaction To BORIS US 60/611,798 Abandoned
NINDS E-274-2004-0-US-01 Methods of Diagnosing and Treating VHL Associated and Sporadic Renal Cell Carcinoma, and Other VHL Associated and Sporadic Counterpart Tumors Which Co-Express EPO and the EPO Receptor US 60/611,616 Abandoned
NIA E-189-2003-0-CA-15 Thalidomide Analogs AS TNF-ALPHA Modulators CA DIV 2808646 Abandoned
NIA E-189-2003-0-EP-12 Thalidomide Analogs AS TNF-ALPHA Modulators EP National Stage 04784385.9 Abandoned
NIA E-189-2003-0-CA-07 Thalidomide Analogs AS TNF-ALPHA Modulators CA National Stage 2538864 Abandoned
NIA E-189-2003-0-JP-09 Thalidomide Analogs AS TNF-ALPHA Modulators JP National Stage 2006-527059 Abandoned